EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Genomtec's enterprise value is zł156.93 Mil.
Genomtec's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was zł0.00 Mil. Therefore, Genomtec's EV-to-Revenue for today is 156,926.00.
The historical rank and industry rank for Genomtec's EV-to-Revenue or its related term are showing as below:
WAR:GMT'
s EV-to-Revenue Range Over the Past 10 Years
Min: 26.09 Med: 492 Max: 174993
Current: 156926
During the past 6 years, the highest EV-to-Revenue of Genomtec was 174993.00. The lowest was 26.09. And the median was 492.00.
WAR:GMT's EV-to-Revenue is ranked worse than 100% of 827
companies
in the Medical Devices & Instruments industry
Industry Median: 3.19
vs WAR:GMT: 156926.00
As of today (2024-05-15), Genomtec's stock price is zł12.98.
Genomtec's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was zł0.00. Therefore, Genomtec's PS Ratio for today is 12,980.00.
Genomtec EV-to-Revenue Historical Data
The historical data trend for Genomtec's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Genomtec's EV-to-Revenue
For the Medical Devices subindustry, Genomtec's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genomtec's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Genomtec's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Genomtec's EV-to-Revenue falls into.
Genomtec's current Enterprise Value is zł156.93 Mil.
Genomtec's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genomtec's share price for today is zł12.98.
Genomtec's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genomtec EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Genomtec's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Genomtec SA is an innovative technology company which works in the area of ?? molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
WAR:GMT has been successfully added to your 